trans-4-Methylpyrrolidin-3-ol hydrochloride

Catalog No.: 
ACMLSV276
CAS No.: 
265108-42-7
Molecular Formula: 
C5H12ClNO
Molecular Weight: 
137.61
trans-4-Methylpyrrolidin-3-ol hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$102.00In stockInquiry
250mg95%$211.00In stockInquiry
1g95%$772.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametrans-4-Methylpyrrolidin-3-ol hydrochloride
IUPAC Name(3R,4S)-4-Methylpyrrolidin-3-ol hydrochloride
MDL No.MFCD19690592
Molecular FormulaC5H12ClNO
Molecular Weight137.61
SMILESO[C@H]1CNC[C@@H]1C.[H]Cl
InChI KeyVBEGDUJNLVSIES-FHAQVOQBSA-N
Synonymtrans-4-Methylpyrrolidin-3-ol hydrochloride | 265108-42-7 | trans-4-Methyl-pyrrolidin-3-ol HCl | TRANS-4-METHYL-PYRROLIDIN-3-OL HYDROCHLORIDE | (3R,4S)-4-methylpyrrolidin-3-ol;hydrochloride | MFCD19690592 | 3-Pyrrolidinol, 4-methyl-, hydrochloride (1:1), (3R,4S)-rel-
CAS No.265108-42-7
PubChem CID67314254

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACMLSV276 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSJMA352 route compound structure diagram
    ACSJMA352885102-33-0In Stock
  2. Then
  3. ACMLSV276 route product structure diagram
    ACMLSV276265108-42-7In Stock
Inquiry

2. ACMLSV276 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMLSV276 route product structure diagram
    ACMLSV276265108-42-7In Stock
Inquiry

3. ACMLSV276 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMLSV276 route product structure diagram
    ACMLSV276265108-42-7In Stock
Inquiry

Comments (0)